APP and Alzheimer disease: APP mutant mice also have defective Nrf2 regulation which is corrected by mitochondria-targeted molecules SS31, MitoQ, DDQ, and others, such as citalopram and curcumin, which reduce AD pathology in cell and mouse models [50,73,80,81,82].